infectious diseases
Human Papillomavirus (HPV) Vaccine
Indications for HPV Vaccine
The HPV vaccine is a routine childhood vaccination (seeCDC: Child and Adolescent Immunization Schedule by Age). The U.S. Food and Drug Administration (FDA)–approved indication for the 9-valent vaccine has recently been expanded to include adults age 27 through 45 years for prevention of certain HPV-related cancers and diseases; the current recommendations from the Advisory Committee on Immunization Practices are For both males and females up to age 26 years:HPV vaccine is recommended at age 11 or 12 years (can start at age 9 years) and for previously unvaccinated or not adequately vaccinated patients up through age 26 years. For adults 27 to 45 years:Clinicians should engage in a shared decision-making discussion with patients to determine whether they should be vaccinated. See alsoCDC: Adult Immunization Schedule by Age. Alternatively (for consideration outside the United States), the following may be used: HPV4 or HPV2 for females HPV4 for males, including those who have sex with men 